FDA Accepts Merck's NDA For Vericiguat For Priority Review - Quick Facts

Merck & Co., Inc. (MRK), known as MSD outside the United States and Canada, announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted for priority review the New Drug Application (NDA) for vericiguat.

from RTT - Biotech https://ift.tt/3ex6GzN
via IFTTT